Is it necessary to continue using Shafinamide Tablets (Siddaco) once taken and analysis of the risks of discontinuation?

Safinamide tablets (Safinamide) is a selective monoamine oxidase B (MAO-B) inhibitor, mainly used in Parkinson's disease (PD) as an adjuvant treatment with levodopa to improve motor symptoms. For patients, once they start taking safinamide, whether it must be continued and the risks after discontinuation are common concerns. Generally speaking, safinamide is a symptomatic auxiliary drug for chronic diseases and needs to be used continuously according to the condition to maintain the drug effect and stabilize symptoms.

In terms of continuous use, safinamine can help prolong the action time of levodopa, reduce the "on-off" phenomenon and movement fluctuations, and improve patients' daily activities. If the drug is stopped for a long time, Parkinson's symptoms may gradually return, including increased stiffness, tremor, and bradykinesia. In addition, some patients may experience mild fatigue, lack of energy, or mood swings in the early stages of drug withdrawal, but overall severe withdrawal reactions are less likely to occur because safinamine does not have obvious dependence like benzodiazepines.

The risk of drug discontinuation is mainly reflected in unstable disease control. If the patient suddenly stops taking safinamine on his own, the original motor symptoms may quickly return or worsen, thus affecting the quality of life. Therefore, it is clinically recommended that if the drug needs to be discontinued, the dosage should be gradually reduced or the treatment plan adjusted under the guidance of a doctor to facilitate a smooth transition and avoid a sharp rebound in symptoms. For patients with obvious symptoms, it is also possible to consider optimizing the dose of levodopa or combining it with other auxiliary drugs for Parkinson's disease to reduce the discomfort caused by drug withdrawal.

Overall, the continued use of safinamine tablets is very important to maintain motor stability in patients with Parkinson's disease. Stopping the drug itself is not likely to cause severe withdrawal reactions, but it may cause the original symptoms to worsen or relapse. Therefore, patients should regularly follow up with neurologists during the medication period to evaluate the efficacy and side effects, and adjust the dosage or combination of medications if necessary to ensure that the treatment is continuous, safe and effective. At the same time, patients should follow the doctor's advice when discontinuing medication under any circumstances to avoid interrupting treatment on their own.

Reference materials:https://www.drugs.com/